Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients.
作者:
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);用药计划表(Drug Administration Schedule);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);男(雄)性(Male);多发性骨髓瘤(Multiple Myeloma);生活质量(Quality of Life);缓解诱导(Remission Induction);回顾性研究(Retrospective Studies);存活率(Survival Rate);沙立度胺(Thalidomide);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.1371/journal.pone.0229469
PMID
32084254
发布时间
2020-05-08
- 浏览4

PloS one
e0229469页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文